Conference Coverage

VIDEO: Novel three-shot immunotherapy regimen


 

AT 2015 AAAAI ANNUAL MEETING

References

HOUSTON– Dr. Amber M. Patterson of Nationwide Children’s Hospital and Research Institute in Columbus, Ohio, provides the lowdown on intralymphatic immunotherapy, in which a three-injection protocol of ultrasound-guided lymph node injections spaced 4 weeks apart is being investigated as a treatment for grass pollen-induced rhinoconjunctivitis in adolescents. It’s an attractive alternative to the conventional 3-year regimen of weekly, then monthly subcutaneous immunotherapy injections.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

bjancin@frontlinemedcom.com

Recommended Reading

Get the baby a dog: Infants’ gut biota seen to affect allergy risk
MDedge Pediatrics
Skin patch therapy for peanut allergy wins plaudits
MDedge Pediatrics
Breastfeeding-related changes in gut bacteria protect against childhood allergy
MDedge Pediatrics
Early consumption of peanuts can induce tolerance in high-risk children
MDedge Pediatrics
Reslizumab aces pivotal trials in asthma with eosinophilia
MDedge Pediatrics
Annual recurrence rate of anaphylaxis in kids is nearly 30%
MDedge Pediatrics
Epinephrine use for anaphylaxis in schools: First national survey
MDedge Pediatrics
Beware common management pitfalls in severe refractory pediatric AD
MDedge Pediatrics
SLIT: Guidelines in progress and practical concerns
MDedge Pediatrics
When to use SLIT and SCID in atopic dermatitis
MDedge Pediatrics